Bio Plus Past Earnings Performance
Past criteria checks 1/6
Bio Plus has been growing earnings at an average annual rate of 35.9%, while the Medical Equipment industry saw earnings growing at 16.2% annually. Revenues have been growing at an average rate of 32.9% per year. Bio Plus's return on equity is 17.6%, and it has net margins of 35%.
Key information
35.9%
Earnings growth rate
22.6%
EPS growth rate
| Medical Equipment Industry Growth | 22.7% |
| Revenue growth rate | 32.9% |
| Return on equity | 17.6% |
| Net Margin | 35.0% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How Bio Plus makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 62,248 | 21,787 | 10,118 | 1,317 |
| 31 Dec 23 | 65,043 | 25,581 | 9,195 | 1,165 |
| 30 Sep 23 | 65,368 | 24,880 | 8,192 | 1,195 |
| 30 Jun 23 | 61,976 | 24,636 | 7,130 | 1,205 |
| 31 Mar 23 | 57,103 | 22,668 | 6,367 | 1,089 |
| 31 Dec 22 | 56,719 | 21,137 | 6,269 | 1,081 |
| 30 Sep 22 | 51,353 | 18,394 | 5,435 | 908 |
| 30 Jun 22 | 45,282 | 12,217 | 5,330 | 618 |
| 31 Mar 22 | 40,612 | 11,269 | 5,222 | 543 |
| 31 Dec 21 | 37,418 | 10,725 | 4,607 | 435 |
| 30 Sep 21 | 35,084 | 10,321 | 4,807 | 462 |
| 30 Jun 21 | 34,574 | 15,182 | 4,501 | 475 |
| 31 Mar 21 | 28,617 | 11,698 | 3,830 | 349 |
| 31 Dec 20 | 24,367 | 9,703 | 3,766 | 276 |
| 30 Sep 20 | 20,551 | 8,251 | 3,406 | 292 |
| 30 Jun 20 | 16,637 | 5,521 | 3,416 | 270 |
| 31 Mar 20 | 17,407 | 6,025 | 3,588 | 146 |
| 31 Dec 19 | 17,021 | 5,623 | 3,617 | 215 |
| 30 Sep 19 | 14,161 | 3,748 | 3,115 | 0 |
| 30 Jun 19 | 13,424 | 3,567 | 2,872 | 0 |
| 31 Mar 19 | 12,213 | 2,982 | 2,603 | 90 |
| 31 Dec 18 | 11,038 | 2,371 | 2,291 | 0 |
| 31 Dec 17 | 3,489 | 376 | 1,113 | 0 |
Quality Earnings: A099430 has a high level of non-cash earnings.
Growing Profit Margin: A099430's current net profit margins (35%) are lower than last year (39.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A099430's earnings have grown significantly by 35.9% per year over the past 5 years.
Accelerating Growth: A099430's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: A099430 had negative earnings growth (-3.9%) over the past year, making it difficult to compare to the Medical Equipment industry average (4.1%).
Return on Equity
High ROE: A099430's Return on Equity (17.6%) is considered low.